BrightGene Bio-Medical Technology Dividends and Buybacks
Dividend criteria checks 1/6
BrightGene Bio-Medical Technology is a dividend paying company with a current yield of 0.32% that is well covered by earnings.
Key information
0.3%
Dividend yield
0.08%
Buyback Yield
| Total Shareholder Yield | 0.4% |
| Future Dividend Yield | 0.4% |
| Dividend Growth | 7.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.096 |
| Payout ratio | 21% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 688166 has been paying a dividend for less than 10 years.
Growing Dividend: 688166's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
| BrightGene Bio-Medical Technology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (688166) | 0.3% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Pharmaceuticals) | 1.7% |
| Analyst forecast (688166) (up to 3 years) | 0.4% |
Notable Dividend: 688166's dividend (0.32%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 688166's dividend (0.32%) is low compared to the top 25% of dividend payers in the CN market (2.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (21.4%), 688166's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 688166 is paying a dividend but the company has no free cash flows.